Twin Tree Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,600
Closed -$163K 1445
2025
Q4
$163K Buy
+1,600
New +$143K ﹤0.01% 1267
2023
Q2
Sell
-1,000
Closed -$23.4K 1348
2023
Q1
$23.4K Hold
1,000
﹤0.01% 1184
2022
Q4
$27.2K Sell
1,000
-10,900
-92% -$499K ﹤0.01% 1209
2022
Q3
$641K Buy
+11,900
New +$611K ﹤0.01% 1101
2020
Q4
Sell
-33,400
Closed -$3.73M 1353
2020
Q3
$3.73M Sell
33,400
-43,200
-56% -$3.95M 0.02% 646
2020
Q2
$6.21M Sell
76,600
-40,600
-35% -$3.27M 0.03% 588
2020
Q1
$8.16M Buy
117,200
+12,000
+11% +$921K 0.04% 373
2019
Q4
$8.22M Buy
+105,200
New +$7.58M 0.03% 396

Other funds holding GH

Twin Tree Management's GH Position: Q2 2023 in Review

Twin Tree Management sold out of Guardant Health (GH) in Q2 2023, closing a stake of 617 shares — an estimated $14.5K sold.

Twin Tree Management first reported a position in GH in Q1 2020 and held it in 7 quarters. The position peaked at $1.66M in Q1 2022. 300 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Twin Tree Management reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Twin Tree Management sold 617 Guardant Health shares in Q2 2023, an estimated $14.5K.
  • Twin Tree Management first reported a position in Guardant Health in Q1 2020 and held it in 7 quarters.
  • Twin Tree Management's Guardant Health position peaked at $1.66M in Q1 2022.
  • 300 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Twin Tree Management's 13F filing for Q2 2023, filed 11 Aug 2023.